Analyzing gene expression profiles with preliminary validations in cardiac hypertrophy induced by pressure overload

Area of Science:

• Cardiovascular Biology
• Molecular Genetics
• Systems Biology

Background:

• Cardiac hypertrophy (CH) is a significant cardiovascular response to pressure overload.
• Understanding the molecular mechanisms underlying CH is crucial for developing targeted therapies.
• Previous studies have identified some genes involved, but a comprehensive analysis of key deregulated genes and pathways is needed.

Purpose of the Study:

• To identify key genes and pathways involved in pressure overload-induced cardiac hypertrophy (CH).
• To analyze differentially expressed genes (DEGs) and their functional enrichment.
• To validate key gene expression changes in a CH model.

Main Methods:

• Downloaded and analyzed mRNA microarray data from Gene Expression Omnibus (GSE5500, GSE18801).
• Screened for differentially expressed genes (DEGs) using the Limma package.
• Performed functional and pathway enrichment analysis using DAVID; validated key DEGs via quantitative PCR.

Main Results:

• Identified 113 common DEGs (60 upregulated, 53 downregulated) in pressure overload-induced CH.
• Upregulated DEGs enriched in neutrophil chemotaxis, extracellular fibril organization, and cell proliferation.
• Downregulated DEGs enriched in ion transport, endoplasmic reticulum, and dendritic spine; pathways include ECM-receptor interaction and focal adhesion.

Conclusions:

• Identified key upregulated genes (e.g., Mfap4, Ltbp2) and downregulated genes (e.g., Anp32a) in cardiac hypertrophy.
• Highlighted significant pathways such as extracellular matrix receptor interaction and focal adhesion.
• These findings provide novel insights into the molecular mechanisms of cardiac hypertrophy.